We are live on ! Find out more

Small Cap
Drug Manufacturers - Specialty & Generic
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
BCRX icon
1
BioCryst Pharmaceuticals
BCRX
$1.9B
$1.9B $7.38 0.94%
ETON icon
2
Eton Pharmaceutcials
ETON
$1.81B
$1.81B $62.90 1.53%
TRLV icon
3
Trulieve Cannabis
TRLV
$1.69B
$1.69B $9.92 3.97%
ANIP icon
4
ANI Pharmaceuticals
ANIP
$1.6B
$1.6B $70.55 0.48%
ALVO icon
5
Alvotech
ALVO
$1.59B
$1.59B $4.46 1.13%
PCRX icon
6
Pacira BioSciences
PCRX
$1.46B
$1.46B $36.48 0%
PAHC icon
7
Phibro Animal Health
PAHC
$1.4B
$1.4B $34.45 1.63%
AMPH icon
8
Amphastar Pharmaceuticals
AMPH
$1.22B
$1.22B $28.64 1.82%
CRON icon
9
Cronos Group
CRON
$1.19B
$1.19B $3.24 0.92%
HROW icon
10
Harrow
HROW
$1.09B
$1.09B $29.17 0.28%
IRWD icon
11
Ironwood Pharmaceuticals
IRWD
$791M
$791M $4.78 1.44%
COLL icon
12
Collegium Pharmaceutical
COLL
$787M
$787M $25.33 0.39%
EVO icon
13
Evotec
EVO
$515M
$515M $1.45 7.05%
TKNO icon
14
Alpha Teknova
TKNO
$480M
$480M $7.63 1.8%
KMDA icon
15
Kamada
KMDA
$465M
$465M $8.06 0.62%
AQST icon
16
Aquestive Therapeutics
AQST
$464M
$464M $3.69 1.86%
EOLS icon
17
Evolus
EOLS
$417M
$417M $6.30 4.98%
TLRY icon
18
Tilray
TLRY
$347M
$347M $2.35 0.43%
ACB icon
19
Aurora Cannabis
ACB
$300M
$300M $4.57 0.87%
EBS icon
20
Emergent Biosolutions
EBS
$291M
$291M $5.66 2.58%

Small Cap Drug Manufacturers - Specialty & Generic Stocks at a Glance

Specialty and generic drug manufacturers develop branded niche therapies, off-patent generics, and animal-health and cannabis products. Generics compete on price and manufacturing scale, while specialty brands carry pharma-like margins on smaller markets.

There are 20 small cap Drug Manufacturers - Specialty & Generic stocks — companies in the Drug Manufacturers - Specialty & Generic industry with a market cap between $250M and $2B — worth a combined $19.8B.

The largest by market cap are BioCryst Pharmaceuticals (BCRX) at $1.9B, Eton Pharmaceutcials (ETON) at $1.81B and Trulieve Cannabis (TRLV) at $1.69B.

Among institutional investors, Eton Pharmaceutcials (ETON) drew the most net new fund positions in Q3 2026: 76 funds opened new positions, taking total fund holders up 49 (30%) quarter-over-quarter.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q3 2026.